Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-80,266
Closed -$7.38M – 4867
2026
Q1
$7.08M Buy
+80,266
New +$6.51M 0.02% 794
2025
Q4
– Sell
-7,620
Closed -$1.13M – 3652
2025
Q3
$1.13M Sell
7,620
-1,044
-12% -$153K ﹤0.01% 1455
2025
Q2
$1.26M Sell
8,664
-17,335
-67% -$2.51M 0.01% 1150
2025
Q1
$3.29M Buy
25,999
+4,075
+19% +$515K 0.02% 600
2024
Q4
$2.28M Buy
+21,924
New +$2.09M 0.01% 683
2023
Q4
– Sell
-88,911
Closed -$4M – 2749
2023
Q3
$4M Buy
88,911
+77,226
+661% +$3.14M 0.04% 369
2023
Q2
$435K Buy
+11,685
New +$468K ﹤0.01% 1437
2023
Q1
– Sell
-87,886
Closed -$2.75M – 2883
2022
Q4
$2.75M Buy
+87,886
New +$3.23M 0.04% 453
2022
Q3
– Sell
-19,250
Closed -$785K – 3206
2022
Q2
$785K Buy
19,250
+7,532
+64% +$279K 0.01% 1097
2022
Q1
$425K Buy
+11,718
New +$389K ﹤0.01% 1964
2021
Q3
– Sell
-15,517
Closed -$498K – 3554
2021
Q2
$498K Buy
15,517
+3,262
+27% +$97.2K ﹤0.01% 1779
2021
Q1
$368K Buy
+12,255
New +$318K ﹤0.01% 1995

Other funds holding LRN

HRT Financial's LRN Position: Q2 2026 in Review

HRT Financial sold out of Stride (LRN) in Q2 2026, closing a stake of 80,266 shares — an estimated $7.38M sold.

HRT Financial first reported a position in LRN in Q1 2021 and held it in 12 quarters. The position peaked at $7.08M in Q1 2026. 414 funds tracked by Wall St. Rank hold LRN as of Q2 2026.

  • HRT Financial reported no remaining Stride position as of Q2 2026 after selling out during the quarter.
  • HRT Financial sold 80,266 Stride shares in Q2 2026, an estimated $7.38M.
  • HRT Financial first reported a position in Stride in Q1 2021 and held it in 12 quarters.
  • HRT Financial's Stride position peaked at $7.08M in Q1 2026.
  • 414 funds tracked by Wall St. Rank held Stride as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.